Successful treatment of recalcitrant eczematous dermatitis with leflunomide

被引：1

作者：

Boyd, Alan S. ^{[1
,2
,3
,4
]}

机构：

[1] Vanderbilt Univ, Dept Med Dermatol, Nashville, TN 37235 USA

[2] Vanderbilt Univ, Dept Pathol, Nashville, TN USA

[3] Vanderbilt Univ, Dept Microbiol, Nashville, TN 37235 USA

[4] Vanderbilt Univ, Dept Immunol, Nashville, TN 37235 USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2013年 / 69卷 / 03期

关键词：

ATOPIC-DERMATITIS;

D O I：

10.1016/j.jaad.2013.04.003

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：E148 / E149

页数：3

共 5 条

[1] Leflunomide in dermatology [J].

Boyd, Alan S. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) :673-679

[2] Significant elevation of serum levels of eotaxin-3/CCL26, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: serum eotaxin-3/CCL26 levels reflect the disease activity of atopic dermatitis [J].

Kagami, S ;

Kakinuma, T ;

Saeki, H ;

Tsunemi, Y ;

Fujita, H ;

Nakamura, K ;

Takekoshi, T ;

Kishimoto, M ;

Mitsui, H ;

Torii, H ;

Komine, M ;

Asahina, A ;

Tamaki, K .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2003, 134 (02) :309-313

[3]

Kehere T, 2001, EUR J ALLERGY CL S68, V56, P144

[4] Leflunomide as a novel treatment option in severe atopic dermatitis [J].

Schmitt, J ;

Wozel, G ;

Pfeiffer, C .

BRITISH JOURNAL OF DERMATOLOGY, 2004, 150 (06) :1182-1185

[5]

Wozel G, 2008, DERMATOL ONLINE J, V12, P6

← 1 →